Indication

Giant cell arteritis

Giant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries. Read more about Giant cell arteritis

152 drugs 105 manufacturers

Advertisement

Drugs that treat it

Common Giant cell arteritis therapies.

Showing 1–9 of 152 drugs

Filter & compare in the drug finder →Opens the drug finder with Giant cell arteritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Giant cell arteritis.

Giant cell arteritis is a chronic, systemic granulomatous vasculitis that primarily targets medium- and large-sized arteries, notably the aorta and the extracranial branches of the carotid arteries.

The condition occurs almost exclusively in adults aged 50 and older, with peak incidence between 70 and 80 years of age and a higher prevalence in women.

Pathophysiologically, transmural vascular inflammation, fragmentation of the internal elastic lamina, and intimal hyperplasia cause luminal narrowing, frequently manifesting as temporal headaches, jaw claudication, scalp tenderness, systemic inflammation, and ischemic complications such as irreversible vision loss.

Personalize your experience

Follow Giant cell arteritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it